Imodium

Loperamide Hydrochloride, the active ingredient in Imodium, is an antidiarrheal presented as an oral tablet for systemic use. It reduces stool frequency and liquidity in adults and children experiencing acute nonspecific diarrhea.

GNH USA supplies Imodium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Imodium is an antidiarrheal that acts on the gastrointestinal motility pathway to control excess stool output. - Acute diarrhea: decreases stool frequency and improves consistency. - Travelers' diarrhea: provides rapid symptom relief for short‑term travel‑related bowel upset. - Irritable bowel syndrome with diarrhea (IBS‑D): helps manage frequent loose stools.

Common Side Effects: - Constipation: reduced bowel movements may become hard. - Abdominal cramps: mild discomfort in the abdomen. - Nausea: occasional feeling of queasiness. - Dry mouth: reduced salivation. - Dizziness: light‑headed sensation. - Fatigue: feeling unusually tired.

Serious or Rare Side Effects: - Severe constipation or ileus: risk of bowel obstruction. - Toxic megacolon: rare but life‑threatening colonic dilation. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Cardiac arrhythmia: QT prolongation especially with interacting drugs. - Central nervous system depression: excessive sedation or respiratory depression when combined with other opioids.

Before using Imodium, consider the following precautions: - Do not exceed recommended dose: follow prescriber or label instructions. - Avoid use in children under 2 years: safety not established. - Use with caution in hepatic impairment: reduced metabolism may increase exposure. - Consult healthcare provider if taking other opioid medications: risk of additive effects. - Store at ambient temperature: keep in the original pack, protect from moisture.

Imodium may interact with several medicines. Major Interactions (Avoid): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): can raise loperamide levels. - Other opioid agonists: may cause additive central nervous system depression. - Quinidine: increases risk of cardiac toxicity. Moderate Interactions (Monitor Closely): - Anticholinergic agents: may worsen constipation. - Rifampin: may reduce loperamide effectiveness. - Sedating antihistamines: can enhance drowsiness.